Cite
MLA Citation
Cornelia L Trimble et al.. “Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.” Lancet, vol. 386, no. 10008, 2015, pp. 2078–2088. http://access.bl.uk/ark:/81055/vdc_100029474537.0x000005